BR0316086A - N-sulfonil-4-metileno amino-3-hidróxi-2-piridonas como agente microbicida - Google Patents

N-sulfonil-4-metileno amino-3-hidróxi-2-piridonas como agente microbicida

Info

Publication number
BR0316086A
BR0316086A BR0316086-6A BR0316086A BR0316086A BR 0316086 A BR0316086 A BR 0316086A BR 0316086 A BR0316086 A BR 0316086A BR 0316086 A BR0316086 A BR 0316086A
Authority
BR
Brazil
Prior art keywords
pyridones
hydroxy
sulfonyl
methylene amino
microbicidal agent
Prior art date
Application number
BR0316086-6A
Other languages
English (en)
Inventor
Namal Chithranga Warshakoon
Rodney Dean Bush
Original Assignee
Procter & Gamble
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Procter & Gamble filed Critical Procter & Gamble
Publication of BR0316086A publication Critical patent/BR0316086A/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/89—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members with hetero atoms directly attached to the ring nitrogen atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyridine Compounds (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Plural Heterocyclic Compounds (AREA)

Abstract

"N-SULFONIL-4-METILENO AMINO-3-HIDRóXI-2-PIRIDONAS COMO AGENTE MICROBICIDA". Compostos de Fórmula (I) são eficazes no tratamento de infecções microbianas.
BR0316086-6A 2002-11-09 2003-11-07 N-sulfonil-4-metileno amino-3-hidróxi-2-piridonas como agente microbicida BR0316086A (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US42507102P 2002-11-09 2002-11-09
PCT/US2003/035623 WO2004043928A2 (en) 2002-11-09 2003-11-07 N-sulfonyl-4-methyleneamino-3-hydroxy-2-pyridones as antimicrobial agents

Publications (1)

Publication Number Publication Date
BR0316086A true BR0316086A (pt) 2005-09-27

Family

ID=32312927

Family Applications (1)

Application Number Title Priority Date Filing Date
BR0316086-6A BR0316086A (pt) 2002-11-09 2003-11-07 N-sulfonil-4-metileno amino-3-hidróxi-2-piridonas como agente microbicida

Country Status (25)

Country Link
US (3) US6946479B2 (pt)
EP (1) EP1558580B1 (pt)
JP (1) JP4327730B2 (pt)
KR (2) KR100894237B1 (pt)
CN (1) CN1708482A (pt)
AT (1) ATE372986T1 (pt)
AU (1) AU2003296045B2 (pt)
BR (1) BR0316086A (pt)
CA (1) CA2502416C (pt)
CO (1) CO5570702A2 (pt)
CY (1) CY1106957T1 (pt)
DE (1) DE60316339T2 (pt)
DK (1) DK1558580T3 (pt)
ES (1) ES2293059T3 (pt)
HR (1) HRP20050517B1 (pt)
IL (1) IL168118A (pt)
MA (1) MA27549A1 (pt)
MX (1) MXPA05004897A (pt)
NO (1) NO331012B1 (pt)
NZ (1) NZ539385A (pt)
PL (1) PL377176A1 (pt)
PT (1) PT1558580E (pt)
RU (1) RU2321584C2 (pt)
WO (1) WO2004043928A2 (pt)
ZA (1) ZA200503682B (pt)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6946479B2 (en) * 2002-11-09 2005-09-20 The Procter & Gamble Company N-sulfonyl-4-methyleneamino-3-hydroxy-2-pyridones
US6930117B2 (en) * 2002-11-09 2005-08-16 The Procter & Gamble Company N-alkyl-4-methyleneamino-3-hydroxy-2-pyridones
US20070275944A1 (en) * 2006-04-05 2007-11-29 The Board Of Trustees Operating Michigan State University Antioxidants and methods of their use
US7622593B2 (en) 2006-06-27 2009-11-24 The Procter & Gamble Company Human protein tyrosine phosphatase inhibitors and methods of use
MX2011007420A (es) 2009-07-06 2011-12-14 Akebia Therapeutics Inc Compuestos, composiciones y metodos para prevenir la metastasis de las celulas cancerigenas.
US8536181B2 (en) 2009-11-06 2013-09-17 Aerpio Therapeutics Inc. Prolyl hydroxylase inhibitors
EP2804604A1 (en) 2011-10-31 2014-11-26 The Methodist Hospital Research Institute Compound comprising a mao targeting/ seeker moiety for treating human gliomas
CN103360308A (zh) * 2012-03-28 2013-10-23 孙伟新 1,4-二羟基-6-甲基-2-吡啶酮类化合物及其制备方法和用途
US20150050277A1 (en) 2013-03-15 2015-02-19 Aerpio Therapeutics Inc. Compositions and methods for treating ocular diseases
JP6572201B2 (ja) 2013-03-15 2019-09-04 エアーピオ セラピューティクス インコーポレイテッド 眼疾患を処置するための組成物、製剤、および方法
US9388135B2 (en) 2014-02-19 2016-07-12 Aerpio Therapeutics, Inc. Process for preparing N-benzyl-3-hydroxy-4-substituted-pyridin-2-(1H)-ones
CN106456614A (zh) 2014-03-14 2017-02-22 爱尔皮奥治疗有限公司 HPTP‑β抑制剂
US9539245B2 (en) 2014-08-07 2017-01-10 Aerpio Therapeutics, Inc. Combination of immunotherapies with activators of Tie-2

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3853900A (en) 1973-09-14 1974-12-10 Searle & Co 4-benzyloxy-2 (1h)-pyridones
US5358949A (en) 1986-03-05 1994-10-25 Otsuka Pharmaceutical Co., Ltd. Carbostyril derivatives and salts thereof and anti-arrhythmic agents containing the carbostyril derivatives
DE4316077A1 (de) 1993-05-13 1994-11-17 Bayer Ag Substituierte Mono- und Bihydridylmethylpyridone
US5789426A (en) 1995-01-20 1998-08-04 Cornell Research Foundation, Inc. Method for the treatment of fibroproliferative disorders by application of inhibitors of protein hydroxylation
US6046219A (en) 1995-01-20 2000-04-04 Cornell Research Foundation, Inc. Method for the treatment of conditions mediated by collagen formation together with cell proliferation by application of inhibitors of protein hydroxylation
US5849587A (en) 1995-06-09 1998-12-15 Cornell Research Foundation, Inc. Method of inhibiting viral replication in eukaryotic cells and of inducing apoptosis of virally-infected cells
US6946479B2 (en) * 2002-11-09 2005-09-20 The Procter & Gamble Company N-sulfonyl-4-methyleneamino-3-hydroxy-2-pyridones

Also Published As

Publication number Publication date
KR100894237B1 (ko) 2009-04-20
US20050256126A1 (en) 2005-11-17
CY1106957T1 (el) 2012-09-26
RU2005114490A (ru) 2006-01-20
JP2006513164A (ja) 2006-04-20
WO2004043928A2 (en) 2004-05-27
US20070238722A1 (en) 2007-10-11
JP4327730B2 (ja) 2009-09-09
AU2003296045B2 (en) 2008-04-03
WO2004043928A8 (en) 2005-05-06
MA27549A1 (fr) 2005-10-03
ZA200503682B (en) 2006-11-29
NZ539385A (en) 2008-02-29
HRP20050517B1 (hr) 2014-03-14
ES2293059T3 (es) 2008-03-16
EP1558580A2 (en) 2005-08-03
AU2003296045A1 (en) 2004-06-03
PT1558580E (pt) 2007-12-06
US6946479B2 (en) 2005-09-20
CA2502416A1 (en) 2004-05-27
US20040097559A1 (en) 2004-05-20
CN1708482A (zh) 2005-12-14
DE60316339D1 (de) 2007-10-25
HRP20050517A2 (en) 2005-12-31
DE60316339T2 (de) 2008-06-05
IL168118A (en) 2011-07-31
CA2502416C (en) 2010-07-20
ATE372986T1 (de) 2007-09-15
PL377176A1 (pl) 2006-01-23
NO331012B1 (no) 2011-09-05
EP1558580B1 (en) 2007-09-12
KR20050055793A (ko) 2005-06-13
RU2321584C2 (ru) 2008-04-10
US7247632B2 (en) 2007-07-24
NO20052788L (no) 2005-06-09
WO2004043928A3 (en) 2004-07-01
DK1558580T3 (da) 2008-01-14
MXPA05004897A (es) 2005-11-17
CO5570702A2 (es) 2005-10-31
KR20070030334A (ko) 2007-03-15

Similar Documents

Publication Publication Date Title
MA27643A1 (fr) Utilisation de n-alkyl-4-methyleneamino-3-hydroxy-2-pyridones en tant qu'agents antimicrobiens
NO20052788L (no) N-sulfonyl-4-metylenamino-3-hydroksy-2-pyridoner som antimikrobielle midler
DE60332137D1 (en) Cyclohexyl-sulphone als gamma-sekretase-inhibitoren
BR0116217A (pt) Quinolonas antimicrobianas, composição farmacêutica, bem como aplicação farmacêutica das referidas quinolonas
ATE376996T1 (de) Antibakterielle mittel
CR7864A (es) Piridodiacinas como fungicidas de plantas
GB0318447D0 (en) Therapeutic agents
ECSP003699A (es) Inhibidores de fab i
ATE420639T1 (de) Antimykotische mittel
AR028706A1 (es) Tiazina oxazolidinona
DE60039183D1 (de) Verbindungen mit antibakteriellen und antiparasitischen eigenschaften
NO20062629L (no) Oksazolderivater av tetrackliner
PE20030061A1 (es) 1-biaril-1,8-naftiridin-4-ona como inhibidores de fosfodiesterasa-4
ES2186550A1 (es) Nuevos derivados de oxazolidinonas como antibacterianos.
MXPA02011039A (es) Combinaciones de productos activos fungicidas.
FI20020507A0 (fi) Antimikrobiaine patogeenisia bakteereita vastaan
UA6944S (uk) Куртка жіноча хутряна, мод. 062а".2001

Legal Events

Date Code Title Description
B06F Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette]
B25A Requested transfer of rights approved

Owner name: WARNER CHILCOTT COMPANY, LLC (PR)

B25A Requested transfer of rights approved

Owner name: AKEBIA THERAPEUTICS INC. (US)

B25A Requested transfer of rights approved

Owner name: AERPIO THERAPEUTICS INC. (US)

B07D Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette]
B07E Notification of approval relating to section 229 industrial property law [chapter 7.5 patent gazette]

Free format text: NOTIFICACAO DE ANUENCIA RELACIONADA COM O ART 229 DA LPI

B07A Application suspended after technical examination (opinion) [chapter 7.1 patent gazette]
B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]

Free format text: REFERENTE A 13A ANUIDADE.

B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]

Free format text: EM VIRTUDE DO ARQUIVAMENTO PUBLICADO NA RPI 2386 DE 27-09-2016 E CONSIDERANDO AUSENCIA DE MANIFESTACAO DENTRO DOS PRAZOS LEGAIS, INFORMO QUE CABE SER MANTIDO O ARQUIVAMENTO DO PEDIDO DE PATENTE, CONFORME O DISPOSTO NO ARTIGO 12, DA RESOLUCAO 113/2013.